Safety and efficacy of blinatumomab: a real world data

In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.
Source: Annals of Hematology - Category: Hematology Source Type: research